Fresenius Medical Care is committed to responsible management that is focused on achieving a sustainable increase in the value of the Company.
Annual General Meetings Archive
Here you will find information on our Annual General Meetings from 2012 to 2023.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
- 2014
- 2013
- 2012
Extraordinary General Meeting 2023
Frequently asked questions regarding the Extraordinary General Meeting (EGM) of Fresenius Medical Care AG & Co. KGaA
Peter Kartscher has been the responsible German Public Auditor since 2020.
Annual General Meeting 2023
The Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on Tuesday, 16 May 2023.
The documents and the further information to be made available pursuant to section 278 (3) AktG in connection with section 124a AktG as well as all other information pertaining to the General Meeting are available below.
"In the run-up to our virtual Annual General Meeting on May 16, 2023, I would like to provide you with a summary of the developments that have been a focus in our conversations with the Management Board and of the important strategic steps that lie ahead of us."
Dr. Dieter Schenk
Chairman of the Supervisory Board
The opening of the Annual General Meeting by the Chairman of the Supervisory Board, Dr. Dieter Schenk, and the report of CEO and Chair of the Management Board, Helen Giza, was transmitted publicly.
The manuscript of the speech of CEO and Chair of the Management Board, Helen Giza, both in German and English, is now available below. As usual with pre-release publications, the spoken word shall prevail.
Annual Financial Statements 2022 according to HGB (German)
Annual Report 2022 (including Consolidated Financial Statements according to IFRS and Non-Financial Group Report 2022)
Report by the Supervisory Board
Report of the General Partner pursuant to section 289a para. 1, section 315a para. 1 HGB
Peter Kartscher has been the responsible German Public Auditor since 2020.
Sustainability disclosures
We are committed to providing transparent and relevant sustainability information to our stakeholders. The tables below give a comprehensive overview of our sustainability performance:
Annual General Meeting 2022
Fresenius Medical Care Shareholder Portal
The General Meeting was broadcasted in full in audio and video on 12 May 2022 from 10:00 hours CEST for registered shareholders via the Shareholder Portal.
The following functions were available to shareholders in the Shareholder Portal:
1. Issue powers of attorney and instructions to the proxies named by the Company
2. Authorization of Third Parties
3. Voting by postal vote
4. Submitting questions to the Company (by 10 May 2022, 24:00 hours CEST, at the latest)
5. Objections (during the General Meeting)
6. Information on the provision of confirmation on whether and how votes were counted pursuant to section 129 (5) AktG (can be found in the Shareholder Portal in a timely manner after the General Meeting)
7. Submission of statements in video form (by 8 May 2022, 24:00 hours CEST, at the latest) and view published statements (until the end of the General Meeting)
Sample proxy form (German)
Annual Financial Statements 2021 according to HGB (German)
Annual Report 2021 (including Consolidated Financial Statements according to IFRS and Non-Financial Group Report 2021)
Peter Kartscher has been the responsible German Public Auditor since 2020.
Sustainability disclosures
We are committed to providing transparent and relevant sustainability information to our stakeholders. The tables below give a comprehensive overview of our sustainability performance:
Below you will find the countermotion from a shareholder within the meaning of Section 126 of the German Stock Corporation Act (Aktiengesetz) on item 4 of the agenda of the virtual Annual General Meeting of Fresenius Medical Care AG & Co. KGaA on May 12, 2022 and the position of the Management.
Annual General Meeting 2021
Annual Financial Statements 2020 according to HGB (German only)
Annual Report 2020 (including Consolidated Financial Statements according to IFRS and Non-financial Group Report)
Sustainability disclosures
We are committed to providing transparent and relevant sustainability information to our stakeholders. The tables below give a comprehensive overview of our sustainability performance:
Below you will find the countermotion from a shareholder within the meaning of Section 126 of the German Stock Corporation Act (Aktiengesetz) on item 4 of the agenda of the virtual Annual General Meeting of Fresenius Medical Care AG & Co. KGaA on May 20, 2021 and the position of the Management.
Annual General Meeting 2020
The 2020 Annual General Meeting of Fresenius Medical Care AG & Co. KGaA took place on August 27, 2020 in a purely virtual form.
At the time of voting 239,542,177 shares with the same amount of votes were represented. This corresponds to 78.68 % of the registered capital.
Annual Financial Statements 2019 according to HGB (German only)
Annual Report 2019 (including Consolidated Financial Statements according to IFRS and Non-financial Group Report)
Annual General Meeting 2019
The Annual General Meeting 2019 of Fresenius Medical Care AG & Co. KGaA was held on May 16, 2019 at the Congress Center, Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany.
At the time the presence was announced, 76.68% of the nominal capital were represented at the Annual General Meeting.
Annual Financial Statements 2018 according to HGB (German only)
Annual Report 2018 (including Consolidated Financial Statements according to IFRS and Non-financial Group Report)
Annual General Meeting 2018
The Annual General Meeting took place at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany on May 17, 2018.
Out of the capital stock of EUR 308,121,322.00, 247,928,768 shares were represented, which accounted for 80.46% of the share capital.
Annual Financial Statements 2017 according to HGB (German only)
Annual Report 2017 according to IFRS (including Consolited Financial Statements and Non-financial Report)
Marked compare version of Articles of Association (agenda item 6)
Annual General Meeting 2017
The Annual General Meeting took place at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany on May 11, 2017.
Out of the capital stock of EUR 307,303,855.00, 236,072,430 shares were represented, which accounted for 76.82 % of the share capital.
Financial statements according to HGB (German only)
Annual General Meeting 2016
The Annual General Meeting took place at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany on May 12, 2016.
Out of the capital stock of EUR 306,368,969.00, 238,277,107 shares were represented, which accounted for 77.77% of the share capital.
Financial statements according to HGB (German only)
Consolidated financial statements according to IFRS (German only)
Convening of the ordinary General Meeting 2011 (marked compare version)
Pooling Agreement 2006 (marked compare version)
Annual General Meeting 2015
The Annual General Meeting took place at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany on May 19, 2015.
Out of the capital stock of EUR 311,490,141.00, 231,089,144 shares were represented, which accounted for 74.19% of the share capital.
Annual General Meeting 2014
The Annual General Meeting took place at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany on May 15, 2014.
Out of the capital stock of EUR 309,137,900, 229,617,455 shares were represented, which accounted for 74.28% of the share capital.
Financial statements and management report 2013 (only in German)
Consolidated financial statements and consolidated management report 2013 (only in German)
Wording of the profit and loss transfer agreement of 23 December 1997 following the amendment agreement of 12 March 2014 (for illustrative purposes)
Financial statements and management report of Fresenius Medical Care AG & Co. KGaA 2013 (only in German)
Financial statements and management report of Fresenius Medical Care AG & Co. KGaA 2012 (only in German)
Financial statements and management report of Fresenius Medical Care AG & Co. KGaA 2011 (only in German)
Financial statements of Fresenius Medical Care Beteiligungsgesellschaft mbH 2013 (only in German)
Financial statements of Fresenius Medical Care Beteiligungsgesellschaft mbH 2012 (only in German)
Financial statements of Fresenius Medical Care Beteiligungsgesellschaft mbH 2011 (only in German)
Annual General Meeting 2013
The ordinary General Meeting took place on May 16, 2013 at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt/Main, Germany.
Out of the ordinary capital stock of EUR 302,921,871, 226,072,802 ordinary shares were represented, which accounted for 74.63% of the ordinary share capital.
138,947 preference shares, which is 3.50% of the preference capital were represented. The capital stock of preference shares is EUR 3,973,333.
All in all, 73.71% of the capital stock of EUR 306,895,204 was represented. This corresponds to 226,211,749 shares.
Separate meeting of preference shareholders 2013
The separate meeting of the preference shareholders took place on May 16, 2013 at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt/Main, Germany.
Out of the preference capital stock of EUR 3,973,333.00, 3,210,711 preference shares were represented, which accounted for 80.81% of the preference share capital.
Annual General Meeting 2012
The Annual General Meeting took place on May 10, 2012 at the Congress Center Messe Frankfurt, Ludwig-Erhard-Anlage 1, 60327 Frankfurt am Main, Germany.
Out of the ordinary capital stock of EUR 300,265,231.00, 234,005,141 ordinary shares were represented, which accounted for 77.93% of the ordinary share capital.
77,617 preference shares, which is 1.96% of the preference capital were represented. The capital stock of preference shares is EUR 3,966,522.00.
All in all, 76.94% of the capital stock of EUR 304,231,753.00 was represented. This corresponds to 234,082,758 shares.
